Product cited in:
Cheng, Wong, Alston, Mackenzie, Huang, Ouyang, Xie, Wiedmann, Rigas: "Aerosol administration of phospho-sulindac inhibits lung tumorigenesis." in: Molecular cancer therapeutics, Vol. 12, Issue 8, pp. 1417-28, 2013 (PubMed).
Zhu, Belkhiri, El-Rifai: "DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib." in: Gastroenterology, Vol. 141, Issue 5, pp. 1738-48.e1-2, 2011 (PubMed).
Shalaby, Presneau, Ye, Halai, Berisha, Idowu, Leithner, Liegl, Briggs, Bacsi, Kindblom, Athanasou, Amary, Hogendoorn, Tirabosco, Flanagan: "The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target." in: The Journal of pathology, Vol. 223, Issue 3, pp. 336-46, 2010 (PubMed).
Zhang, Ji, Yu, Overholtzer, Smolen, Wang, Brugge, Dyson, Haber: "YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway." in: Nature cell biology, Vol. 11, Issue 12, pp. 1444-50, 2009 (PubMed).
Bhuvaneswari, Gan, Soo, Olivo: "Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response." in: Molecular cancer, Vol. 8, pp. 94, 2009 (PubMed).